qPCR analysis showed that the JAK2-STAT3 signaling pathway was activated in the mutants, and inhibition of JAK2 partially rescued the anemic phenotype, which may be a potential therapeutic drug for ribosomal deficiency-induced anemia. This evidence concerns the gene JAK2 and anemia.